Prelude therapeutics to participate in upcoming healthcare conferences

Wilmington, del., june 02, 2025 (globe newswire) -- prelude therapeutics incorporated (prelude) (nasdaq: prld), a clinical-stage precision oncology company, announced today that the company will participate in two upcoming healthcare conferences in june.

PRLD Ratings Summary

PRLD Quant Ranking